PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 23, 2022Advances in Medical Sciences122 citationsOpen Access

What do we know about inflammatory myofibroblastic tumors? – A systematic review

View Full Paper
KSKrzysztof SiemionJRJoanna Reszeć-GiełażynJKJoanna Kiśluk

Key Points

Key points are not available for this paper at this time.

Abstract

IMTs are rare neoplasms, which have not been investigated in detail due to the difficulty in collecting a large number of cases. Thus, our knowledge about this disease remains unsatisfactory. Recently developed techniques such as next-generation sequencing and computer-aided histopathological diagnosis may be useful in understanding the etiopathology of IMTs, which will help in the selection of the most appropriate therapy for patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Siemion et al. (2022) studied this question.

synapsesocial.com/papers/69d75e5eb6e34cdcae48f3d1https://doi.org/10.1016/j.advms.2022.02.002
Ask AI
Helpful
Bookmark
Share
View Full Paper